Navigation Links
Drug Companies May Be Penalize For Overcharging NHS Tax Payers Money on Branded Drugs

The Nation Health Care System of Britain, the NHS, has been in constant light over the past few years. This focus has become even more acute// |as it tries desperately to repair itself from collapsing.

A recent report by the Office of Fair Trading, has expressed that the NHS may actually be paying Drug companies millions of pounds more then they should, for branded drugs.

A conclusive study carried out by the watchdog from 1995 on the purchasing of drugs by the NHS from Pharma companies, has brought to light some interesting facts. The officially published of this study, may perhaps highly fluctuate the stocks of some of the top Pharma companies.

It is anticipated that the Head of The Office of Fair Trading, John Fingleton will be reveling the findings of this inquiry to 10 downing street within this week. Consequence of which could well mean a reduction in the profit margins of all Pharma companies supply drugs to the NHS.

Currently, branded Pharma companies under the Pharmaceutical Price Regulation Scheme can legally charge up to 21% profit on any medicine they sell to the NHS. However, generic drug companies are able to produce and sell copycat drugs much cheaper to the branded treatments.

Branded companies argue that they need to make back returns on the hours and millions spent on research then trials before a drug can be successfully launched into the market. A reduction on profit margins could well have harsh consequence on research and development of newer drugs for the British Pharmaceuticals companies.

The government has an extremely tough road ahead of them. With branded drug companies not going to yield without a good fight, generic drug companies waiting in the wing and millions of pounds of tax payer’s money at stake.
R.S
'"/>




Page: 1

Related medicine news :

1. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
2. Pharma Companies May Influence The Decisions Of Medical Students
3. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
4. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
5. Doctors, Pharma Companies Targeted By CBI Raids
6. Raids Conducted In Hospitals And Pharmaceutical Companies
7. Australia to Show Leniency towards U.S. Pharmaceutical Companies
8. Pharma Companies Tie Up To Develop Bird Flu Vaccine
9. Companies Not Doing Enough To Fight Bird Flu
10. Food Companies show Pathetic Response to Health Crisis
11. Medicare Drug Plans Might Rest With Three Major Insurance Companies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... ... facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year anniversary of ... opportunity for area-residents to celebrate two great years while also familiarizing themselves with ...
(Date:3/27/2017)... HOUSTON, Texas (PRWEB) , ... March 27, 2017 , ... ... and hard of hearing, is bringing its latest products to the Deaf Seniors of ... attendees will have the opportunity to meet with knowledgeable ASL friendly staff from Harris ...
(Date:3/25/2017)... ... 2017 , ... Norland at Swissray is pleased to announce the release of the ... ELITE DXA has an active scan window, which is more than double that of existing ... scan area could not undergo an accurate total body bone density or body composition study. ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... will spark a conversation on the current obstacles facing infection prevention and offer ... preventable deaths caused by these infections. , The print component of “Fighting ...
(Date:3/24/2017)... ... 2017 , ... The Radiology Business Management Association (RBMA) has named ... in their 12th year, are among the most prestigious in radiology marketing because a ... were retooled to recognize achievements in both large budget (over $5,000) and small budget ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
(Date:3/27/2017)... NEW YORK , March 27, 2017 ... and technology platform for value-based precision medicine, ... multi-year collaboration with Novartis Pharmaceuticals Corporation to ... breast cancer patients. As part ... the previous announced collaboration entered into January ...
(Date:3/27/2017)... 2017 Arena Pharmaceuticals, Inc. (NASDAQ: ... small molecule drugs across multiple therapeutic areas, today announced that ... will present a corporate update at the 16th Annual Needham ... conference will take place April 4-5, 2017 at the Westin ... , NY.  A live audio webcast of ...
Breaking Medicine Technology: